PMC:7031805 / 26247-28214
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7031805","sourcedb":"PMC","sourceid":"7031805","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7031805","text":"Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: S.F.T. is a PI on research grants from Janssen and Allergan to Emory University; is a paid consultant for Janssen; is a member of the SAB for Sage Therapeutics, the GRIN2B Foundation, and CureGRIN; is cofounder of NeurOp Inc; receives licensing fees and royalties for software; and is a co-inventor on Emory University-owned Intellectual Property that includes allosteric modulators of glutamate receptor function. D.D. receives salary support from the Commonwealth of Pennsylvania Department of Health, Pediatric Epilepsy Research Foundation, and The Epilepsy Study Consortium and is an investigator on research grants awarded to CHOP from the Commonwealth of PA Department of Health, Zogenix, Greenwich Biosciences, UCB, Brain Sentinel, Neurelis, Q-State, USL, Aquestive, Bio-Pharm, Insys, SK Life Sciences, and Encoded Therapeutics. D.C.H. is a coinventor on US patent no. US 9,803,200 B2, “Inhibition of microRNA-134 for the treatment of seizure-related disorders and neurologic injuries.” A.P. serves on the scientific advisory board of Tevard and has a spouse/partner who receives a salary from Sanofi Genzyme. H.C.M. is a member of scientific advisory boards for Lennox Gastaut Syndrome Foundation, Dravet Syndrome Foundation, and SPARK. M.A.R. is principal investigator on research grants to the University of California, Davis, from NINDS (U54NS079202, R25NS099170, U01NS112102) and Mallinckrodt Pharmaceuticals; has served as a consultant to Eisai, West Therapeutics Development, Xenon Pharmaceuticals, and Aquestive Therapeutics; is a member of the board of directors of Epalex; is a member of the scientific advisory board of Zynerba Pharmaceuticals; and is named as an inventor of patents and patent applications assigned to the Regents of the University of California.","tracks":[{"project":"testtesttest","denotations":[{"id":"T51","span":{"begin":908,"end":913},"obj":"Body_part"}],"attributes":[{"id":"A51","pred":"uberon_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A52","pred":"uberon_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/UBERON_6110636"},{"subj":"T51","pred":"source","obj":"testtesttest"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"testtesttest","color":"#93ebec","default":true}]}]}}